Novel Therapy Approved by the European Commission for Hidradenitis suppurativa/Acne inversa

Only recently (July 2015), the European Commission and the FDA (US Food and Drug Administration) has approved a novel drug for Hidradenitis suppurativa/Acne inversa (HS). It is the first and only approved drug for HS. HS is a chronic inflammatory disease which is characterized by recurrent, painful abscesses leading also to psychological impairment. Until now, in all new responsive Webdesign online

We are happy to announce that is now up to date with an all new responsive webdesign which helps reading information on mobile devices. The mobile webdesign of our website makes it more accessible for everyone and content like contact data and medical information is easier to grasp. Short overview of the new features: Responsive

22.09.2015|Categories: General|Tags: , , |